1. Phase III study of intermittent carmustine (BCNU) cyclophosphamide and prednisone versus melphalan and prednisone in multiple myeloma;ABRAMSON, N.; LURIE, P.; MIETLOWSKI, W.L.; SCHILL-ING, A.; BENNETT, J.M.; HORTON, J.;Cancer Treatment Reports,1982
2. Chemotherapy for multiple myeloma;ALEXANIAN, R.; DREICER, R.;Cancer,1984
3. Combination chemotherapy for multiple myeloma;ALEXANIAN, R.; GEHAN, E.; BONNET, J.; HAUT, A.; HEWLETT, J.; LANE, M.; McKELVEY, E.M.; MIGLIORE, P.H.; STUCKEY, W.J.; WILSON, H.E.;Cancer,1972
4. Unmaintained remissions in multiple myeloma;ALEXANIAN, R.; GEHAN, E.; HAUT, A.; SAIKI, J.; WEICK, J.;Blood,1978
5. Prednisone pulse therapy for refractory myeloma;ALEXANIAN, R.; YAP, B.S.; BODEY, G.P.;Blood,1983